Literature DB >> 32817033

Pharmacologic treatment of alcohol use disorder.

Caitlin R Finley1, Carly Rumley2, Christina S Korownyk3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32817033      PMCID： PMC7430770     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  Acamprosate: safety and tolerability in the treatment of alcohol dependence.

Authors:  Richard N Rosenthal; Allyson Gage; James L Perhach; Anita M Goodman
Journal:  J Addict Med       Date:  2008-03       Impact factor: 3.702

2.  Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.

Authors:  P Heinälä; H Alho; K Kiianmaa; J Lönnqvist; K Kuoppasalmi; J D Sinclair
Journal:  J Clin Psychopharmacol       Date:  2001-06       Impact factor: 3.153

Review 3.  Acamprosate for alcohol dependence.

Authors:  Susanne Rösner; Andrea Hackl-Herrwerth; Stefan Leucht; Philippe Lehert; Simona Vecchi; Michael Soyka
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

4.  How Much Is Too Much? Patterns of Drinking During Alcohol Treatment and Associations With Post-Treatment Outcomes Across Three Alcohol Clinical Trials.

Authors:  Katie Witkiewitz; Corey R Roos; Matthew R Pearson; Kevin A Hallgren; Stephen A Maisto; Megan Kirouac; Alyssa A Forcehimes; Adam D Wilson; Charles S Robinson; Elizabeth McCallion; J Scott Tonigan; Nick Heather
Journal:  J Stud Alcohol Drugs       Date:  2017-01       Impact factor: 2.582

Review 5.  Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

Authors:  Daniel E Jonas; Halle R Amick; Cynthia Feltner; Georgiy Bobashev; Kathleen Thomas; Roberta Wines; Mimi M Kim; Ellen Shanahan; C Elizabeth Gass; Cassandra J Rowe; James C Garbutt
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

Review 6.  Opioid antagonists for alcohol dependence.

Authors:  Susanne Rösner; Andrea Hackl-Herrwerth; Stefan Leucht; Simona Vecchi; Manit Srisurapanont; Michael Soyka
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

7.  Primary health care utilization for alcohol-attributed diseases in British Columbia Canada 2001-2011.

Authors:  Amanda K Slaunwhite; Scott Macdonald
Journal:  BMC Fam Pract       Date:  2015-03-11       Impact factor: 2.497

8.  Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.

Authors:  Monica Bolton; Alex Hodkinson; Shivani Boda; Alan Mould; Maria Panagioti; Sarah Rhodes; Lisa Riste; Harm van Marwijk
Journal:  BMC Med       Date:  2019-01-15       Impact factor: 8.775
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.